1. The Solute Carrier MFSD1 Decreases the Activation Status of β1 Integrin and Thus Tumor Metastasis
   Marko Roblek et al, 2022, Frontiers in Oncology CrossRef
2. Gangliosides as Biomarkers of Human Brain Diseases: Trends in Discovery and Characterization by High-Performance Mass Spectrometry
   Mirela Sarbu et al, 2022, International Journal of Molecular Sciences CrossRef
3. Glycosylation Changes in Brain Cancer
   Lucas Veillon et al, 2018, ACS Chemical Neuroscience CrossRef